3.07

6.97% -0.23

Nanobiotix Adr (NBTX)

Overview News Price History Discussions Forecast

Nanobiotix Adr stock is traded at $3.07, with a volume of 2,703. It is down -6.97% in the last 24 hours and down -26.17% over the past month. Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Previous Close:

$3.30

Open:

$3.28

24h Volume:

2,703

Relative Volume:

0.09

Market Cap:

$145.53M

Revenue:

$27,600

Net Income/Loss:

$-36.04M

P/E Ratio:

-3.8529

EPS:

-0.7968

Net Cash Flow:

$-1.66M

1W Performance:

-9.17%

1M Performance:

-26.17%

6M Performance:

-37.98%

1Y Performance:

-51.65%

1-Day Range:

$3.07

$3.28

1-Week Range:

$2.95

$3.60

52-Week Range:

$2.76

$7.51

Nanobiotix Adr Stock (NBTX) Company Profile

Name

Nanobiotix Adr

Sector

Healthcare (1169)

Industry

Biotechnology (679)

Phone

Address

Employee

110

Twitter

Next Earnings Date

2024-11-10

Latest SEC Filings

NBTX's Discussions on Twitter

Compare NBTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NBTX Nanobiotix Adr	3.07	145.53M	27,600	-36.04M	-1.66M	-0.7968
VRTX Vertex Pharmaceuticals Inc	502.92	129.14B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	680.61	74.41B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	581.21	35.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.75	31.30B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.57	27.35B	3.32B	-860.46M	-1.04B	-8.32